Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsThe advent of Chimeric Antigen Receptor T-cell (CAR-T) therapies has revolutionized the field of oncology, providing new avenues for treating various forms of cancer. Our 20 years of experience in the biotechnology sector have equipped us with the expertise and technological capabilities to support the entire lifecycle of CAR-T products, from early development to commercialization.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsGet a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORE
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Welcome to Creative Biolabs' Good Manufacturing Practices (GMP) grade virus manufacturing services designed specifically for CAR-T therapies. Our state-of-the-art facility is fully compliant with GMP, ensuring that we produce high-quality viral vectors that meet regulatory standards. We specialize in the production of lentiviruses, adenoviruses, and other viral vectors essential for the development of cutting-edge cell therapies. With a dedicated team of experts and a commitment to innovation, we provide tailored solutions that streamline the manufacturing process and support your research trials, enabling you to advance your CAR-T therapies with confidence.
GMP Grade Virus refers to viral preparations that are produced according to Good Manufacturing Practices (GMP). These practices ensure that biological products, including viruses, are consistently produced and controlled in a quality manner suitable for their intended use, particularly in clinical trials and therapeutic applications.
GMP-grade viruses are essential for various applications, including:
GMP standards cover various aspects of production, including the quality of starting materials, the production environment, monitoring and testing for contaminants, documentation, and traceability. Meeting these standards helps to ensure that the final product is safe for use in humans
Creative Biolabs is excited to offer our specialized GMP Grade Virus Manufacturing service for CAR-T therapies. Our state-of-the-art facility is equipped to produce high-quality viral vectors under stringent GMP regulations, ensuring that every batch meets the rigorous standards required for clinical applications. Our team of experienced scientists and engineers is dedicated to optimizing the production process, providing you with reliable and scalable solutions tailored to meet your specific project needs. By partnering with us, you can be confident in the quality and efficacy of your CAR-T products, facilitating advancements in personalized immunotherapies.
The production of GMP-grade virus vectors used in CAR T therapy involves several critical steps to ensure safety, quality, and efficacy. Firstly, the process begins with the selection of suitable viral vectors, often derived from lentiviruses or retroviruses, followed by the design of the CAR construct. Once the vector is engineered, stringent quality control measures are employed during the cell culture phase, where producer cell lines are maintained under controlled conditions to ensure consistent yields of viral particles. Following this, purification processes, such as ultracentrifugation or chromatography, are implemented to isolate the viral particles from cellular debris and other contaminants. Each batch undergoes rigorous testing for potency, identity, and sterility to meet regulatory standards.
We are ready to help you with your GMP-grade virus manufacturing needs. For any inquiries, quotes, or to discuss your specific requirements, please feel free to contact us. You can reach us via email at info@creative-biolabs.com. Additionally, feel free to fill out our online contact form on our website, and we'll get back to you promptly. Let us partner with you in advancing your CAR-T therapies through high-quality viral vector production.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
